Zura Bio Limited company info

What does Zura Bio Limited do?
Zura Bio (NASDAQ:ZURA) is a clinical-stage biotechnology company focused on developing innovative medicines for immune and inflammatory disorders. They currently have three assets in Phase 2 ready stage, targeting conditions like systemic sclerosis and other unmet medical needs. With a focus on novel therapies like tibulizumab (ZB-106) and torudokimab (ZB-880), Zura Bio aims to demonstrate their efficacy, safety, and dosing convenience. Despite a potentially overvalued stock, their strong balance sheet suggests they have the resources to advance their pipeline and potentially revolutionize treatment options for patients with these challenging conditions.
Zura Bio Limited  company media
Company Snapshot

Is Zura Bio Limited a public or private company?

key
Ownership
Public

How many people does Zura Bio Limited employ?

people
Employees
15

What sector is Zura Bio Limited in?

pie chart
Sector
Health Care

Where is the head office for Zura Bio Limited ?

location pin
Head Office
California, United States

What year was Zura Bio Limited founded?

founded flag
Year Founded
2022
What does Zura Bio Limited specialise in?
/Biotechnology Company /Drug Development /Cancer Treatments /Immunotherapy Services /Research Projects /Investment Opportunities

What are the products and/or services of Zura Bio Limited ?

Overview of Zura Bio Limited offerings
Drug Pipeline: This is the core of Zura Bio's activity. It likely consists of several drug candidates in various stages of development, targeting specific immune and inflammatory disorders.
Lead Candidates: Zura Bio might have 2-3 drug candidates in the most advanced stages (potentially Phase 2 ready), like tibulizumab (ZB-106) and torudokimab (ZB-880).
Technology Platform: They might have a proprietary technology platform for developing novel immunotherapies or other treatments relevant to their focus area.
Intellectual Property: Patents and other intellectual property would be crucial to protect their discoveries and potential commercialization of successful drugs.
Research Partnerships: Collaborations with academic institutions or other companies might be part of their strategy to accelerate drug development.
Investor Relations: Publicly traded companies like Zura Bio need to maintain investor relations activities to raise capital and keep investors informed about their progress.

Who is in the executive team of Zura Bio Limited ?

Zura Bio Limited leadership team
  • Dr. Someit  Sidhu M.D.
    Dr. Someit Sidhu M.D.
    Founder & Non-Independent Director
  • Mr. Verender S. Badial
    Mr. Verender S. Badial
    Chief Financial Officer
  • Dr. Michael D. Howell Ph.D.
    Dr. Michael D. Howell Ph.D.
    Chief Scientific Officer
  • Ms. Kimberly Ann Davis
    Ms. Kimberly Ann Davis
    Chief Legal Officer & Secretary
  • Mr. Robert  Lisicki
    Mr. Robert Lisicki
    President, CEO & COO
  • Dr. Gary  Whale Ph.D.
    Dr. Gary Whale Ph.D.
    Chief Technology Officer
  • Ms. Theresa  Lowry
    Ms. Theresa Lowry
    Chief Human Resources Officer
  • Mr. David  Brady
    Mr. David Brady
    Head of Business Development